Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59

European Journal of Immunology

Volumn 33, Issue 2, 2003, Pages 522-531

  Clayton, Aled ^a   Harris, Claire L ^a   Court, Jacquelyn ^a   Mason, Malcolm D ^a   Morgan, B Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antigen presenting cell; CD55; CD59; Complement; Exosome

Indexed keywords

CANCER VACCINE; CD59 ANTIGEN; COMPLEMENT COMPONENT C3B; DECAY ACCELERATING FACTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CELL SURVIVAL; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DENDRITIC CELL; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; MONOCYTE; PRIORITY JOURNAL; REVIEW;

ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; CELL DIFFERENTIATION; CELLS, CULTURED; COMPLEMENT ACTIVATION; COMPLEMENT C3B; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; FLUORESCEINS; FLUORESCENT DYES; HUMANS; MEMBRANE GLYCOPROTEINS; MONOCYTES; ORGANELLES;

EID: 0345701525     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/immu.200310028     Document Type: Review

References (44)

1. Fernandez-Borja, M., Wubbolts, R., Calafat, J., Jansen, H., Divecha, N., Dusseljee, S. and Neefjes, J., Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr. Biol. 1999. 9: 55-58.
2. Geuze, H. J., A novel lysosomal compartment engaged in antigen presentation. Eur. J. Cell. Biol. 1994. 64: 3-6.
3. Kleijmeer, M. J., Morkowski, S., Griffith, J. M., Rudensky, A. Y. and Geuze, H. J., Major histocompatability complex II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J. Cell. Biol. 1997. 139: 639-649.
4. Johnstone, R. M., Mathew, A., Mason A. B. and Teng, K., Exosome formation during maturation of mamalian and avian reticulocytes: evidence that exosome release is a major route for externalisation of obsolete membrane proteins. J. Cell. Pathol. 1991. 147: 27-36.
5. Heijnen, H. F. G., Schiel, A. E., Fijnheer, R., Gauze, H. J. and Sixma, J. J., Activated platelets pelease two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and α-granules. Blood 1999. 94: 3791-3799.
6. Peters, P. J., Borst, J., Oorschot, V., Fukuda, M., Krahenbuh, O., Tsxchopp, J., Slot, J. W. and Geuze, H. J., Cytotoxic T lymphocyte granules are secretory lysosomes containing both perforin and granzymes. J. Exp. Med. 1991. 173: 1099-1109.
7. Blanchard, N., Lankar, D., Faure, F., Regnault, A., Dumont, C., Raposo, G. and Hivroz, C., TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J. Immunol. 2002. 168: 3235-3241.
8. Karlsson, M., Lundin, S., Dahlgren, U., Kahu, H., Pettersson, I. and Telemo, E., "Tolerosomes" are produced by intestinal epithelial cells. Eur. J. Immunol. 2001. 31: 2892-2900.
9. van Niel, G., Raposo, G., Candalh, C., Boussac, M., Hershberg, R., Cerf-Bensussan, N. and Heyman, M., Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001. 121: 337-349.
10. Raposo, G., Nijman, H. W., Stoorvogel, W., Leijendekker, R., Harding, C. V., Melief, C. J. M. and Geuze, H. J., B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996. 183: 1161-1172.
11. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Filament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G. and Amigorena, S., Eradication of established murine tumours using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 1998. 4: 594-600.
12. Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Thery, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., Angevin, E., Amigorena, S. and Zitvogel, L., Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 2001. 7: 297-303.
13. Escola, J.-M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O. and Geuze, H. J., Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 1998. 273: 20121-20127.
14. Clayton, A., Court, J., Navabi, H., Adams, M., Mason, M. D. Hobot, J. A., Newman, G. R. and Jasani, B., Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods 2001. 247: 163-174.
15. Thery, C., Regnault, A., Garin, J., Wolfers, J., Zitvogel, L., Ricciardi-Castagnoli, P., Raposo, G. and Amigorena, S., Molecular characterisation of dendritic cell-derived exosomes: selective accumulation of the heat shock protein hsc73. J. Cell. Biol. 1999. 147: 599-610.
16. Rabesandrata, H., Toutant, J., Reggio, H. and Vidal, M., Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during in vitro maturation of reticulocytes. Blood 1998. 91: 2573-2580.
17. Thery, C., Boussac, M., Veron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J. and Amigorena, S., Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 2001. 166: 7309-7318.
18. Wassef, N. M., Matyas, G. R. and Alving, C. R., Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of stealth lipids. Biochem. Biophys. Res. Commun. 1991. 176: 866-874.
19. Liu, D., Liu, F. and Song, Y. K., Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. Biochim. Biophys. Acta 1995. 1235: 140-146.
20. Corvo, M. L., Boerman, O. C., Oyen, W. J., Van-Bloois, L., Cruz, M. E., Crommelin, D. J. and Storm, G., Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim. Biophys. Acta. 1999. 1419: 325-334.
21. Yoshikawa, Y., Miyazaki, M., Houjou, T., Komuta, Y., Yoshikawa, H. and Takada, K., Biodistribution of cyclosporin encapsulated in liposomes modified with bioadhesive polymer. J. Pharm. Pharmacol. 1997. 49: 661-668.
22. Srinath, P., Vyas, S. P. and Diwan, P. V., Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug Dev. Ind. Pharm. 2000. 26: 313-321.
23. Kim, A., Yun, M. O., Oh, Y. K., Ahn, W. S. and Kim, C. K., Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. Int. J. Pharm. 1999. 180: 75-81.
24. Bradley, A. J., Brooks, D. E., Norris-Jones, R. and Devine, D. V., C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner. Biochim. Biophys. Acta 1999. 1418: 19-30.
25. Bradley, A. J., Devine, D. V., Ansell, S. M., Janzen, J. and Brooks, D. E., Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch. Biochem. Biophys. 1998. 357: 185-194.
26. Devine, D. V., Wong, K., Serrano, K., Chonn, A. and Cullis, P. R., Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta 1994. 1: 43-51.
27. Harashima, H., Hiraiwa, T., Ochi, Y. and Kiwada, H., Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling. J. Drug Target. 1995. 3: 253-261.
28. Harashima, H., Ochi, Y. and Kiwada, H., Kinetic modelling of liposome degradation in serum: effect of size and concentration of liposomes in vitro. Biopharm. Drug Dispos. 1994. 15: 217-225.
29. Oglesby, T. J., Allen, C. J., Liszewski, M. K., White, D. J. and Atkinson, J. P., Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J. Exp. Med. 1992. 175: 1547-1551.
30. Brodbeck, W. G., Mold, C., Atkinson, J. P. and Medof, M. E., Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack. J. Immunol. 2000. 165: 3999-4006.
31. Rollins, S. A. and Sims, P. J., The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol. 1990. 144: 3478-3483.
32. Meri, S., Morgan, B. P., Davies, A., Daniels, R. H., Olavesen, M. G., Waldmann, H. and Lachmann, P. J., Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 1990. 71: 1-9.
33. Brasoveanu, L. I., Fonsatti, E., Visintin, A., Pavlovic, M., Cattarossi, I., Colizzi, F., Gasparollo, A., Coral, S., Horejsi, V., Altomonte, M. and Maio, M., Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity. J. Clin. Invest, 1997. 100: 1248-1255.
34. Blok, V. T., Daha, M. R., Tijsma, O., Harris, C. L., Morgan, B. P., Fleuren, G. J. and Gorter, A., A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement. J. Immunol. 1998. 160: 3437-3443.
35. Morgan, B. P. and Meri, S., Membrane proteins that protect against complement lysis. Springer Semin. Immunopathol. 1994. 15: 369-396.
36. Harris, C. L. and Morgan, B. P., Characterisation of a glycosyl phosphatidylinositol anchor deficient subline of Raji Cells. Immunology 1995. 86: 311-318.
37. Rooney, I. A., Atkinson, J. P., Krul, E. S., Schonfeld, G., Polakoski, K., Saffitz, J. E. and Morgan, B. P., Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis. J. Exp. Med. 1993. 177: 1409-1420.
38. Doyle, A., Griffiths, J. B. and Newel, D. G., Cell and tissue culture: laboratory procedures. Wiley, Porton Down 1994.
39. Storkus, W. J., Alexander, J., Payne, J. A., Cresswell, P. and Dawson, J. R., The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing. J. Immunol. 1989. 143: 3853-3857.
40. Navabi, H., Jasani, B., Adams, M., Evans, A., Crosby, T., Mason, M. and Borysiewicz, L., Generation of in vitro autologous human cytotoxic T cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells. Adv. Exp. Med. Biol. 1997. 147: 583-589.
41. Abraha, A., Morgan, B. P. and Luzio, J. P., The preparation and characterisation of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunits. Biochem. J. 1988. 251: 285-292.
42. Harris, C. L., Lublin, D. M. and Morgan, B. P., Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: pitfalls and solutions. J. Immunol. Methods 2002. 268: 245-258.
43. Stefanova, I., Hilgert, I., Kristofova, H., Brown, R., Low, M. G. and Horejsi, V., Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol. Mol. Immunol. 1989. 26: 153-161.
44. Vanderpuye, O. A., Labarrere, C. A. and McIntyre, J. A., Expression of CD59, a human complement system regulatory protein, in extraembryonic membranes. Int. Arch. Allergy Immunol. 1993. 101: 376-384.